2023
Use of Wearable Devices in Individuals With or at Risk for Cardiovascular Disease in the US, 2019 to 2020
Dhingra L, Aminorroaya A, Oikonomou E, Nargesi A, Wilson F, Krumholz H, Khera R. Use of Wearable Devices in Individuals With or at Risk for Cardiovascular Disease in the US, 2019 to 2020. JAMA Network Open 2023, 6: e2316634. PMID: 37285157, PMCID: PMC10248745, DOI: 10.1001/jamanetworkopen.2023.16634.Peer-Reviewed Original ResearchConceptsHealth Information National Trends SurveyUS adultsExacerbate disparitiesWearable device usersCardiovascular diseaseCardiovascular healthPopulation-based cross-sectional studySelf-reported cardiovascular diseaseCardiovascular disease risk factorsNational Trends SurveyOverall US adult populationCardiovascular risk factor profileSelf-reported accessAssociated with lower useUse of wearable devicesImprove cardiovascular healthLower household incomeLower educational attainmentUS adult populationRisk factor profileNationally representative sampleCross-sectional studyProportion of adultsTrends SurveyWearable device data
2021
Prevalence and trends of coronary artery disease risk factors and their effect on age of diagnosis in patients with established coronary artery disease: Tehran Heart Center (2005–2015)
Hosseini K, Mortazavi S, Sadeghian S, Ayati A, Nalini M, Aminorroaya A, Tavolinejad H, Salarifar M, Pourhosseini H, Aein A, Jalali A, Bozorgi A, Mehrani M, Kamangar F. Prevalence and trends of coronary artery disease risk factors and their effect on age of diagnosis in patients with established coronary artery disease: Tehran Heart Center (2005–2015). BMC Cardiovascular Disorders 2021, 21: 477. PMID: 34607557, PMCID: PMC8491372, DOI: 10.1186/s12872-021-02293-y.Peer-Reviewed Original ResearchConceptsCAD risk factorsRisk factorsTehran Heart CenterOpium useDisease risk factorsEffect of opium useCoronary artery disease risk factorsArtery disease risk factorsMiddle-income countriesYears earlier ageHigher risk of CADHeart CenterCAD diagnosisCross-sectional studyPublic health challengeArtery diseaseAssociated with higher riskBody-mass indexRisk of CADConventional CAD risk factorsAge of CAD onsetLipid profile componentsTraditional risk factorsHypertension prevalenceAge of diagnosis
2020
Population attributable fraction estimates of cardiovascular diseases in different levels of plasma total cholesterol in a large-scale cross-sectional study: a focus on prevention strategies and treatment coverage
Azadnajafabad S, Karimian M, Roshani S, Rezaei N, Mohammadi E, Saeedi Moghaddam S, Ghasemi E, Sadeghi Morasa F, Rezaei N, Aminorroaya A, Ghanbari A, Nasserinejad M, Gorgani F, Larijani B, Farzadfar F. Population attributable fraction estimates of cardiovascular diseases in different levels of plasma total cholesterol in a large-scale cross-sectional study: a focus on prevention strategies and treatment coverage. Journal Of Diabetes & Metabolic Disorders 2020, 19: 1453-1463. PMID: 33520846, PMCID: PMC7843742, DOI: 10.1007/s40200-020-00673-3.Peer-Reviewed Original ResearchHighest population attributable fractionPopulation attributable fractionIschemic heart diseasePrevention strategiesCalculated population attributable fractionsPopulation attributable fraction estimationPopulation-based prevention strategiesNon-communicable diseasesRisk factorsIschemic strokeBurden of hypercholesterolemiaCross-sectional studyPhase 1Phase 2Iran STEPsAttributable fractionUrgent action planHealth guidelinesPrevention programsPhase 3Treatment coverageImpact of treatmentPurposeCardiovascular diseaseLevels of plasma total cholesterolLipid-lowering drugsAnti-modified citrullinated vimentin antibody: a novel biomarker associated with cardiac systolic dysfunction in patients with rheumatoid arthritis
Norouzi S, Javinani A, Aminorroaya A, Masoumi M. Anti-modified citrullinated vimentin antibody: a novel biomarker associated with cardiac systolic dysfunction in patients with rheumatoid arthritis. BMC Cardiovascular Disorders 2020, 20: 390. PMID: 32847506, PMCID: PMC7448352, DOI: 10.1186/s12872-020-01676-x.Peer-Reviewed Original ResearchConceptsLeft ventricular ejection fractionCardiac systolic dysfunctionCardiovascular diseaseSystolic dysfunctionRheumatoid arthritisReduced left ventricular ejection fractionPredictors of left ventricular ejection fractionAnti-modified citrullinated vimentinEchocardiographic parameters of systolicDisease Activity Score-28Anti-MCV levelsParameters of systolicAssociation of autoantibodiesVentricular ejection fractionConcomitant cardiovascular diseaseExclusion of patientsSusceptibility to cardiovascular diseaseReceiver operating characteristic curveDuration of diseaseCardiovascular disease risk factorsAnti-citrullinated proteinFramingham risk scoreCross-sectional studyTransthoracic echocardiographyDiastolic dysfunction